Characteristics of patients with and without allergic disease from benralizumab phase iii severe asthma trials

Allergic disease is commonly associated with asthma. We compared demographics and baseline clinical characteristics of patients with and without allergic disease from the benralizumab SIROCCO (NCT01928771) and CALIMA (NCT01914757) Phase III studies.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: P106 Source Type: research